Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib.

Source:http://linkedlifedata.com/resource/pubmed/id/19481800

Download in:

View as

General Info

PMID
19481800